mirtazapine has been researched along with Co-infection in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iannetta, M | 1 |
| Bellizzi, A | 1 |
| Lo Menzo, S | 1 |
| Anzivino, E | 1 |
| D'Abramo, A | 1 |
| Oliva, A | 1 |
| D'Agostino, C | 1 |
| d'Ettorre, G | 1 |
| Pietropaolo, V | 1 |
| Vullo, V | 1 |
| Ciardi, MR | 1 |
| Loignon, M | 1 |
| Toma, E | 1 |
1 review available for mirtazapine and Co-infection
| Article | Year |
|---|---|
Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Coinfection; Cy | 2016 |
1 other study available for mirtazapine and Co-infection
| Article | Year |
|---|---|
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Topics: Adrenal Cortex Hormones; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Fatal | 2013 |